ANBT
MRNA icon

American National Bank & Trust’s Moderna MRNA Stock Holding History

American National Bank & Trust’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-521
Closed -$15.4K – 675
2025
Q4 		$15.4K Hold
521
– – ﹤0.01% 473
2025
Q3 		$13.5K Sell
521
-880
-63% -$24.5K ﹤0.01% 494
2025
Q2 		$38.7K Hold
1,401
– – ﹤0.01% 407
2025
Q1 		$39.7K Hold
1,401
– – ﹤0.01% 357
2024
Q4 		$58.3K Hold
1,401
– – 0.01% 304
2024
Q3 		$93.6K Buy
1,401
+500
+55% +$45.9K 0.01% 260
2024
Q2 		$107K Hold
901
– – 0.01% 259
2024
Q1 		$96K Buy
901
+880
+4,190% +$88.7K 0.01% 248
2023
Q4 		$2.09K Hold
21
– – ﹤0.01% 483
2023
Q3 		$2.17K Hold
21
– – ﹤0.01% 509
2023
Q2 		$2.55K Hold
21
– – ﹤0.01% 487
2023
Q1 		$3.23K Hold
21
– – ﹤0.01% 464
2022
Q4 		$4K Sell
21
-11
-34% -$1.8K ﹤0.01% 438
2022
Q3 		$4K Buy
32
+11
+52% +$1.67K ﹤0.01% 433
2022
Q2 		$3K Sell
21
-178
-89% -$25.4K ﹤0.01% 375
2022
Q1 		$34K Buy
199
+69
+53% +$11.6K 0.01% 226
2021
Q4 		$33K Buy
130
+109
+519% +$31.9K 0.01% 217
2021
Q3 		$8K Hold
21
– – ﹤0.01% 257
2021
Q2 		$5K Hold
21
– – ﹤0.01% 252
2021
Q1 		$3K Buy
+21
New +$3.04K ﹤0.01% 245

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

American National Bank & Trust's MRNA Position: Q1 2026 in Review

American National Bank & Trust sold out of Moderna (MRNA) in Q1 2026, closing a stake of 521 shares — an estimated $15.4K sold.

American National Bank & Trust first reported a position in MRNA in Q1 2021 and held it in 20 quarters. The position peaked at $107K in Q2 2024. 726 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • American National Bank & Trust reported no remaining Moderna position as of Q1 2026 after selling out during the quarter.
  • American National Bank & Trust sold 521 Moderna shares in Q1 2026, an estimated $15.4K.
  • American National Bank & Trust first reported a position in Moderna in Q1 2021 and held it in 20 quarters.
  • American National Bank & Trust's Moderna position peaked at $107K in Q2 2024.
  • 726 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on American National Bank & Trust's 13F filing for Q1 2026, filed 24 Apr 2026.